or Try an Advanced Search...

    Technical Analysis for BCTX - BriaCell Therapeutics Corp.

    Grade Last Price % Change Price Change
    F 2.15 -0.57% -0.01
    BCTX closed down 0.57 percent on Thursday, April 18, 2024, on 10 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical BCTX trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    New Downtrend Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish -0.57%
    Lower Bollinger Band Walk Weakness -0.57%
    Inside Day Range Contraction -0.57%
    Older End-of-Day Signals for BCTX ...

       Recent Intraday Alerts

    Alert Time
    Gap Up Closed about 10 hours ago
    Reversed from Up about 10 hours ago
    60 Minute Opening Range Breakdown about 12 hours ago
    Rose Above Previous Day's High about 14 hours ago
    Gap Up Partially Closed about 14 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BCTX Chart by TradingView
    Basic chart:

    Profile

    BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer

    Is BCTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 10 BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer
    Apr 9 BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR
    Mar 7 BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies
    Mar 6 BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
    Feb 27 BriaCell Provides Update on Alleged Illegal Trading of Public Securities
    Feb 7 BriaCell shares rise on strong data from breast cancer treatment study
    Feb 7 BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
    Feb 6 Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
    Jan 31 BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
    Jan 4 BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer
    See more BCTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.59
    52 Week Low 2.02
    Average Volume 88,694
    200-Day Moving Average 4.83
    50-Day Moving Average 3.01
    20-Day Moving Average 2.61
    10-Day Moving Average 2.53
    Average True Range 0.25
    RSI (14) 31.97
    ADX 25.55
    +DI 12.75
    -DI 30.58
    Chandelier Exit (Long, 3 ATRs) 2.27
    Chandelier Exit (Short, 3 ATRs) 2.78
    Upper Bollinger Bands 3.11
    Lower Bollinger Band 2.12
    Percent B (%b) 0.03
    BandWidth 38.00
    MACD Line -0.21
    MACD Signal Line -0.17
    MACD Histogram -0.0396
    Fundamentals Value
    Market Cap 34.32 Million
    Num Shares 16 Million
    EPS -1.73
    Price-to-Earnings (P/E) Ratio -1.24
    Price-to-Sales 0.00
    Price-to-Book 23.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.48
    Resistance 3 (R3) 2.51 2.43 2.42
    Resistance 2 (R2) 2.43 2.35 2.41 2.40
    Resistance 1 (R1) 2.29 2.29 2.36 2.26 2.39
    Pivot Point 2.21 2.21 2.24 2.19 2.21
    Support 1 (S1) 2.07 2.13 2.14 2.04 1.91
    Support 2 (S2) 1.99 2.07 1.97 1.89
    Support 3 (S3) 1.85 1.99 1.87
    Support 4 (S4) 1.82